CompletedPhase 2NCT01005199

Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver Cancer

Studying Adult hepatocellular carcinoma

Last synced from ClinicalTrials.gov May 3, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Swiss Cancer Institute
Principal Investigator: Dieter Koeberle, MD
Cantonal Hospital of St. Gallen
Intervention: everolimus(drug)
Enrollment: 106 enrolled
Eligibility: 18 years · All sexes
Timeline: 2009 – 2016

Study locations (15)

Medizinische Universität Wien, Vienna, Austria
Szent Laszlo Korhaz, Budapest, Hungary
Saint Claraspital AG, Basel, Switzerland
Clinical Cancer Research Center at University Hospital Basel, Basel, Switzerland
Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland
Inselspital Bern, Bern, Switzerland
Kantonsspital Bruderholz, Bruderholz, Switzerland
Hopital Cantonal Universitaire de Geneve, Geneva, Switzerland
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Kantonsspital Liestal, Liestal, Switzerland
Kantonsspital - St. Gallen, Sankt Gallen, Switzerland
CHCVS - Hôpital de Sion, Sion, Switzerland
Regionalspital, Thun, Switzerland
City Hospital Triemli, Zurich, Switzerland
UniversitaetsSpital Zuerich, Zurich, Switzerland

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01005199 on ClinicalTrials.gov

Other trials for Adult hepatocellular carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Adult hepatocellular carcinoma →

← Back to all trials